This post‐translational modification reduces the sumoylation and ubiquitination of microphthalmia‐associated transcription factor (MITF) mediated by PIAS3, which then activates purine metabolism and promotes the progression of GC. This evidence concerns the gene PIAS3 and gastric cancer.